Synprosis Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Synprosis General Information
Description
Manufacturer of peptides intended for research and therapeutic applications. The company's products include resins, amino acids, coupling reagents, vaccines for malaria, cancer, allergies neurogenerative diseases and treatment of pain.
Contact Information
Website
www.synprosis.comCorporate Office
- 59, Avenue Sainte Victoire
- Zac Saint Charles
- 13710 Fuveau
- France
Corporate Office
- 59, Avenue Sainte Victoire
- Zac Saint Charles
- 13710 Fuveau
- France
Synprosis Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Synprosis Signals
Synprosis Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Synprosis FAQs
-
When was Synprosis founded?
Synprosis was founded in 2003.
-
Who is the founder of Synprosis?
Jean Salles is the founder of Synprosis.
-
Where is Synprosis headquartered?
Synprosis is headquartered in Fuveau, France.
-
What is the size of Synprosis?
Synprosis has 8 total employees.
-
What industry is Synprosis in?
Synprosis’s primary industry is Drug Discovery.
-
Is Synprosis a private or public company?
Synprosis is a Private company.
-
What is Synprosis’s current revenue?
The current revenue for Synprosis is
. -
Who are Synprosis’s investors?
Incubateur Impulse and Provepharm have invested in Synprosis.
-
When was Synprosis acquired?
Synprosis was acquired on 01-Apr-2022.
-
Who acquired Synprosis?
Synprosis was acquired by Bachem Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »